XTL Biopharmaceuticals Ltd.
XTLB
$2.92
$0.031.04%
NASDAQ
| 12/31/2025 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -- | -7.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -- | -7.36% | |||
| Operating Income | -- | 7.36% | |||
| Income Before Tax | -- | 40.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -- | 40.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -- | 40.93% | |||
| EBIT | -- | 7.36% | |||
| EBITDA | -- | 7.37% | |||
| EPS Basic | -- | 42.86% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | 14.29% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | 0.00% | |||
| Average Diluted Shares Outstanding | 1.41% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||